Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

The purpose of this study is to determine whether levetiracetam is safe and well tolerated by patients while suffering a status epilepticus. Levetiracetam is added to the standard treatment of patients with this disease.

  • 27 views
  • 07 Nov, 2020
  • 1 location
A Study of Chios Mastic Water in Irritable Bowel Syndrome

Chios mastic is a natural product with strong antimicrobial, anti-inflammatory and antioxidant properties, and well-established benefits for dyspeptic disorders. The aim of the present study is to investigate the effectiveness of a natural aqueous extract of Chios mastic (mastic water), a by-product of Chios mastic processing, in the management of …

gastrointestinal symptoms
body mass index
  • 0 views
  • 02 Jun, 2021
  • 1 location
Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain

nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. In HIV there are no FDA-approved drugs for this indication. This study assesses in a randomized controlled

  • 0 views
  • 13 Mar, 2021
  • 1 location
Intravenous Methylprednisolone Versus Oral Prednisolone for Infantile Spasms

directed over the past years to evaluate the role of various anticonvulsants in the management of IS. High dose oral prednisolone has been shown to cause early cessation of spasms and resolution of

epilepsy
oral prednisolone
anticonvulsants
epileptic spasms
prednisolone
  • 11 views
  • 23 Jan, 2021
  • 1 location
The Study on the Esketamine in the Treatment of Postherpetic Neuralgia

herpes zoster heals and persists for a long time. At present, clinically anticonvulsants (such as gabapentin, pregabalin) and antidepressants (such as amitriptyline) are clinically first-line drugs for

  • 0 views
  • 27 Jan, 2021
  • 1 location
The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

PDN, among others, Gabapentin, Pregabalin and anticonvulsants until the pain subsides. Unfortunately, this treatment is only aimed at relieving the symptoms of existing pain but not working on

  • 0 views
  • 26 Jan, 2021
  • 1 location
Effectiveness of Combined Levetiracetam and Midazolam in Generalized Convulsive Status Epilepticus in Children

Generalized status epilepticus is a common pediatric neurological emergency with significant mortality and morbidity. Benzodiazepines remain the first anticonvulsive line but benzo-diazepines don't control seizures in about 30% of cases. GCSE may be more rapidly stopped and controlled through combining another drug with benzodiazepines such as Levetiracetam, acting by different …

  • 0 views
  • 18 Jul, 2021
  • 1 location
Topiramate and Schizophrenia: Effects on Weight and Psychopathology

Clozapine is the sole AP agent with superiority in treatment refractory schizophrenia, but it also is associated with the greatest risk of weight gain and other metabolic abnormalities. Topiramate, an anticonvulsant agent, possesses a weight-reducing effect. Furthermore, some studies have suggested that Topiramate may be associated with improvements in psychopathology …

  • 14 views
  • 29 Jun, 2021
  • 1 location
Improving Outcomes and Lowering Costs by Integration of Primary Care Providers and Pain Medicine Physicians for Pain Pts

This study will demonstrate that functional improvement measures over a 6-month period for chronic low back patients under the care of Primary Care Provider (PCP), using a therapeutic plan formulated initially by the Pain Medicine Specialist (PMS), are equivalent to those under the care of the PMS only. Chronic low …

low back pain
analgesics
analgesia
back pain
pain relieving
  • 0 views
  • 02 May, 2021
  • 1 location
Botulinum Toxin Injections for Oral Neuropathic Pain

Peripheral painful traumatic trigeminal neuropathy (PPTTN) are poorly relieved by existing treatments which in addition induce many adverse effects. BTX, which blocks the exocytosis of neurotransmitters, can be captured by axonal retrograde transport in primary nociceptive neurons. Injected in the painful area, it might therefore inhibit the release of algogenic …

  • 0 views
  • 26 Jan, 2021
  • 1 location